AstraZeneca Aktie
150,95
EUR
-1,40
EUR
-0,92
%
152,20
EUR
+0,65
EUR
+0,43
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
AstraZeneca Aktie Analyse
| 01.02.12 | AstraZeneca neutral | Banc of America Securities-Merrill Lynch | |
| 01.02.12 | AstraZeneca reduce | Nomura | |
| 22.12.11 | AstraZeneca halten | Independent Research GmbH | |
| 21.12.11 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 21.12.11 | AstraZeneca reduce | Nomura | |
| 16.12.11 | AstraZeneca halten | Independent Research GmbH | |
| 15.12.11 | AstraZeneca hold | Deutsche Bank AG | |
| 13.12.11 | AstraZeneca underperform | Credit Suisse Group | |
|
Werbung
|
|||
| 09.12.11 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 08.12.11 | AstraZeneca neutral | Citigroup Corp. | |
| 30.11.11 | AstraZeneca neutral | Citigroup Corp. | |
| 03.11.11 | AstraZeneca halten | Independent Research GmbH | |
| 28.10.11 | AstraZeneca hold | HSBC | |
| 28.10.11 | AstraZeneca reduce | Nomura | |
| 27.10.11 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 27.10.11 | AstraZeneca buy | Citigroup Corp. | |
| 25.10.11 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 19.10.11 | AstraZeneca underperform | Credit Suisse Group | |
| 17.10.11 | AstraZeneca buy | UBS AG | |
| 11.10.11 | AstraZeneca buy | UBS AG | |
| 10.10.11 | AstraZeneca buy | Citigroup Corp. | |
| 06.10.11 | AstraZeneca hold | Deutsche Bank AG | |
| 06.10.11 | AstraZeneca overweight | Morgan Stanley | |
| 08.09.11 | AstraZeneca hold | Royal Bank of Scotland | |
| 05.09.11 | AstraZeneca hold | Royal Bank of Scotland | |
| 05.09.11 | AstraZeneca buy | Citigroup Corp. | |
| 31.08.11 | AstraZeneca hold | Deutsche Bank AG | |
| 01.08.11 | AstraZeneca halten | Independent Research GmbH | |
| 29.07.11 | AstraZeneca buy | UBS AG | |
| 29.07.11 | AstraZeneca buy | Citigroup Corp. | |
| 21.07.11 | AstraZeneca buy | Citigroup Corp. | |
| 21.07.11 | AstraZeneca reduce | Nomura | |
| 20.07.11 | AstraZeneca buy | UBS AG | |
| 20.07.11 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 20.07.11 | AstraZeneca reduce | Nomura | |
| 20.07.11 | AstraZeneca buy | Citigroup Corp. | |
| 20.07.11 | AstraZeneca buy | UBS AG | |
| 19.07.11 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 18.07.11 | AstraZeneca overweight | Morgan Stanley | |
| 18.07.11 | AstraZeneca buy | UBS AG | |
| 18.07.11 | AstraZeneca reduce | Nomura | |
| 18.07.11 | AstraZeneca buy | Citigroup Corp. | |
| 15.07.11 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 13.07.11 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 12.07.11 | AstraZeneca reduce | Nomura | |
| 30.06.11 | AstraZeneca buy | UBS AG | |
| 29.06.11 | AstraZeneca buy | Citigroup Corp. | |
| 27.06.11 | AstraZeneca buy | UBS AG | |
| 27.06.11 | AstraZeneca overweight | Morgan Stanley | |
| 27.06.11 | AstraZeneca buy | Citigroup Corp. | |
Werbung
Werbung